The Effect of PD-1 Inhibitor Combined with Chemotherapy on the Level of Peripheral Blood T Lymphocytes among Patients with Non-Small-Cell Lung Cancer and Its Relationship with Prognosis

Table 1

Comparison of general information [ (%)].

Factors	Observation group ()	Control group ()
Gender			0.024	0.877
Male	40 (51.95)	37 (50.68)
Female	37 (48.05)	36 (49.32)
Age (years)			0.110	0.701
≤61	38 (49.35)	38 (52.05)
>61	39 (50.65)	35 (47.95)
BMI (kg/m^2)			0.036	0.849
≤23	41 (53.25)	40 (54.79)
>23	36 (46.75)	33 (45.21)
History of smoking			0.019	0.891
Yes	42 (54.55)	39 (53.42)
No	35 (45.45)	34 (46.58)
Clinical stage			0.001	0.983
Stage IIIB	36 (46.75)	34 (46.58)
Stage IV	41 (53.25)	39 (53.42)
Pathological type			0.057	0.972
Squamous cell carcinoma	21 (27.27)	19 (26.03)
Adenocarcinoma	46 (59.74)	45 (61.64)
Others	10 (12.99)	9 (12.33)
Tumor location			0.036	0.849
Left lung	41 (53.25)	40 (54.79)
Right lung	36 (46.75)	33 (45.21)